Team:Tsinghua
From 2014.igem.org
(Difference between revisions)
Line 18: | Line 18: | ||
</div> | </div> | ||
<div id="text1" class="slideLeft"> | <div id="text1" class="slideLeft"> | ||
- | <h1 class="customtext | + | <h1 class="customtext">Hi! We are <font color="990099">Team Tsinghua</font>. We present to you a <font color="990099">gene therapy</font> for Type 1 Diabetes Mellitus (T1DM).</h1> |
</div> | </div> | ||
</span> | </span> |
Revision as of 12:17, 15 October 2014
![](https://static.igem.org/mediawiki/2014/2/23/Tsinghua_Emoji-2.png)
T1DM results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.
![](https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png)
Scroll down
![](https://static.igem.org/mediawiki/2014/4/4a/Tsinghua_Logo300x409.png)
We use Adeno-associated virus (AAV) as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?
![](https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png)
Scroll down